Chemours Co (CC)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents US$ in thousands 1,203,000 852,000 738,000 816,000 1,102,000 1,167,000 1,248,000 1,145,000 1,451,000 1,031,000 1,139,000 1,008,000 1,105,000 956,000 1,031,000 714,000 943,000 694,000 630,000 697,000
Short-term investments US$ in thousands 178,000 167 182
Total current liabilities US$ in thousands 2,486,000 2,925,000 2,190,000 1,745,000 1,891,000 1,951,000 1,886,000 1,775,000 1,858,000 1,779,000 1,674,000 1,501,000 1,442,000 1,308,000 1,156,000 1,343,000 1,541,000 1,643,000 1,448,000 1,572,000
Cash ratio 0.48 0.29 0.34 0.47 0.58 0.60 0.66 0.65 0.78 0.58 0.79 0.67 0.77 0.73 0.89 0.53 0.61 0.42 0.44 0.44

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($1,203,000K + $—K) ÷ $2,486,000K
= 0.48

The cash ratio of Chemours Co has displayed fluctuations over the past few quarters. The ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents.

As of December 31, 2023, the cash ratio stood at 0.48, indicating that for every dollar of current liabilities, the company had $0.48 in cash and cash equivalents. This ratio was lower compared to the previous quarter's ratio of 0.58 and continues a declining trend since the high of 0.89 in June 2020.

The decreasing trend in the cash ratio could imply that Chemours Co may have been using its cash for investments, operations, or other activities rather than keeping it in cash and cash equivalents. A lower cash ratio may suggest a higher risk of liquidity issues if the company faces unexpected financial obligations in the short term.

It is essential for investors and stakeholders to monitor the cash ratio along with other financial indicators to assess the company's liquidity and financial health effectively.


Peer comparison

Dec 31, 2023